Background: Deep anterior lamellar keratoplasty (DALK) is indicated to correct high astigmatism in patients with keratoconus (KC) and no evidence of Descemet's membrane rupture. However, some patients with KC experience graft rejection-like inflammatory reactions within 2 months (usually in the first week) after DALK. The aim of this study was to identify the characteristics and influencing factors of these reactions by reviewing the records of patients who underwent DALK or penetrating keratoplasty (PKP) for KC or other corneal problems. Methods: We retrospectively reviewed the medical records of patients who underwent DALK for KC (DALK/KC), PKP for KC (PKP/KC), or DALK for other corneal problems (DALK/ non-KC) at Ban Buntane Hotokukai Hospital between January 2006 and December 2015 and who were followed for more than 1 year. We collected data on the characteristics and incidence of severe inflammatory graft reactions in the early postoperative phase (ie, within 2 months after keratoplasty) and visual outcomes after these inflammatory reactions. Results: Postoperative inflammatory reactions characterized by persistent epithelial defects, loose suture with infiltration, and vessel invasion occurred in seven of eleven DALK/KC patients, three of 50 DALK/non-KC patients, and none of five PKP/KC patients. These reactions were nonresponsive to topical steroids, and suture removal was required. Although a clear corneal graft in the pupillary area was obtained and best-corrected visual acuity was good after the resolution of inflammation, a risk of corneal astigmatism remained.
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In patients with keratoconus (KC), DALK is thought to be preferable to PKP to correct high astigmatism due to the irregular shape of the cornea, when the corneal endothelium is healthy and there is no evidence of DM rupture. However, despite the progress in surgical techniques, postoperative complications -mainly corneal epithelial, subepithelial, and stromal rejection -may lead to graft failure in DALK for KC. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Stromal rejection is characterized by acute stromal edema and haze followed by vascularization confined to the area of the graft. [4] [5] [6] Although stromal rejection is usually well controlled by topical steroids, it may still cause graft failure. 13 We have previously experienced graft rejection-like inflammatory reactions within 2 months (usually in the first week) after DALK in patients with KC. The aim of this study was to identify the characteristics and influencing factors of these graft reactions by reviewing the records of patients who underwent DALK or PKP for KC or other corneal problems.
Methods
To identify the characteristics and influencing factors of inflammatory graft reactions after DALK, we retrospectively reviewed the medical records of patients who underwent DALK for KC (DALK/KC), PKP for KC (PKP/KC), or DALK for other corneal problems (DALK/non-KC) at Ban Buntane Hotokukai Hospital between January 2006 and December 2015 and who were followed for more than 1 year. To determine the incidence of postoperative complications and visual outcomes of DALK for KC, we compared the data from the patients who underwent DALK for other corneal problems (DALK/non-KC) in the same period. Eyes with a past history of herpetic keratitis were excluded because of the possibility of revealing unexpected inflammatory reactions after surgery. This study was approved by the Ethics Review Committee of Fujita Health University Faculty of Medicine (approval number: HM17-160) and in accordance with the Declaration of Helsinki. Written informed consent was obtained from each patient for surgery and use of the clinical records for future research.
All procedures were performed by one of the authors (KH). In moderate to advanced KC, DALK or PKP was performed due to intolerance to contact lenses and poor spectacle-corrected visual acuity. For DALK, the recipient's cornea was cut with a Hessburg-Barron trephine (Katena Products, Denville, NJ, USA) down to 350 µm deep, with a diameter of either 7.00 or 7.50 mm. A layer-by-layer technique with Sugita's hydrodissection 14 and Tsubota's divideand-conquer technique 15 were used for the manual removal of the stromal tissue with or without baring of DM. Exposure of DM was limited around the pupillary area, and in many cases, DM was not exposed when the removal of the stromal tissue reached a relatively smooth surface under the surgical microscope. The donor's corneal graft was prepared from the fresh sclerocorneal button with a Barron donor punch (Katena Products) with the same diameter or 0.25 mm larger than the recipient's trephine. DM and endothelial cells were not removed from the donor corneal button. The sclerocorneal button was preserved in 2.5% chondroitin sulfate dextran (Optisol ® , Chiron Ophthalmics, Irvine, CA, USA) and was used for surgery within 10 days after the donor's death. The corneal graft was sutured to the host cornea with 8 interrupted and 16 or 24 running 10-0 nylon sutures (nylon 1404; trape spatula; Mani ® , Tochigi, Japan). For PKP, a trephine of either 7.00 or 7.50 mm in diameter was used, and the graft diameter was the same as that of the trephine or 0.25 mm larger; graft suture was performed as described above for DALK. Local anesthesia by sub-Tenon's injection of 2% lidocaine was administered for the surgery, except in patients with mental disorders who needed general anesthesia.
For the statistical analysis, Fisher's exact test was used to determine if postoperative complications were significantly different between DALK/KC and DALK/non-KC. The MannWhitney U test was used to determine if postoperative corneal astigmatism was significantly different among the three groups (DALK/KC, PKP/KC, and DALK/non-KC). Results were considered statistically significant when P,0.05.
Results
Characteristics of patients who underwent keratoplasty
DALK was performed in eleven eyes of eleven patients with KC (DALK/KC), and PKP was performed in five eyes of five patients with KC (PKP/KC) ( Tables 1 and 2 ). The average age and male:female ratio of each group were 37.8 (range, 22-54) years old and 7:4, and 51.0 (range, 29-81) years old and 4:1, respectively. Among the five PKP/KC patients, four had a history of acute hydrops and one was converted from DALK because of DM rupture during surgery. Among the eleven DALK/KC patients, secondary corneal amyloidosis was observed in six eyes, causing irritation before surgery. Except for PKP/KC case #2, all patients with KC had allergic problems, including atopic dermatitis, allergic rhinitis, and ocular allergy. At the time of surgery, any ocular allergic disorders, including allergic conjunctivitis and vernal keratoconjunctivitis, were well controlled, either with steroid or antiallergy eye drops, in all KC patients. In the same period, DALK was performed for 50 eyes of 45 non-KC patients (DALK/non-KC) ( Table 3 ). The average age of the DALK/non-KC patients was 65.5 (22-89) years old, and the male:female ratio was 22:28. None of the patients in the three groups had a history of herpetic keratitis.
Postoperative complications graft reactions within 2 months postoperatively
As listed in Table 4 , unfavorable graft reactions characterized by persistent epithelial defect (PED), suture loosening with infiltration, vessel invasion (vascularization), and graft melting were seen in seven of eleven DALK/KC patients in the early postoperative period (ie, within 2 months after DALK) (Figures 1  and 2 and Table 4 , gray cells). These reactions occurred in none of five PKP/KC patients and three of 50 DALK/non-KC patients, for whom DALK was performed for corneal stromal opacity after infectious corneal ulcer, cholesterol metabolism abnormality, and unknown lipid degeneration.
Suture-related complications, graft infiltration, and vascularization in the early postoperative period did not respond well to topical steroids or therapeutic soft contact lenses. Therefore, removal of the loosened 10-0 nylon was required. After removal of the running suture, interrupted sutures were added and 0.1% betamethasone eye drops were applied until the inflammatory symptoms subsided, which took 2 weeks to 20 months (average 7.6 months) from the time of the first inflammatory sign.
stromal rejection
Stromal rejection occurred in two of eleven DALK/KC patients (cases #8 and #11) at 9 and 6 months after surgery, respectively, and in case #11, stromal edema occurred after the early graft reactions subsided. Among the 50 DALK/ non-KC patients, the same reactions were observed in one case of unknown stromal opacity 6 months after DALK. Stromal rejection responded well to topical steroids (0.1% betamethasone phosphate eye drops four times daily) in the three DALK patients, and the reactions subsided within a couple of weeks. Figure 3 shows the incidence of postoperative complications in DALK/KC and DALK/non-KC patients. The incidence of postoperative complications in PKP/KC patients is not shown because there were no such complications. Although the number of cases was small, PED, suture loosening, suture infiltration in the early postoperative period, and vascularization were more frequent among DALK/KC eyes compared with DALK/non-KC eyes (P=0.02, P,0.001, P,0.001, and P,0.002, respectively). Figure 4 shows the corneal astigmatism after corneal transplantation in the three groups. Because of the difficulty of controlling corneal curvature by the early postoperative inflammatory reactions, mean astigmatism and its SD were larger in the DALK/KC group than in the other DALK cases (5.66±4.59 D vs 3.19±2.05 D, P=0.12). However, BCVA after surgery was improved in almost all cases either by using glasses or rigid contact lenses (Table 1) .
Comparison of postoperative complications
surgical outcomes (astigmatism and bestcorrected visual acuity [BCVa])
secondary corneal amyloidosis patients
One of the main features of this series of cases was the high incidence of secondary corneal amyloidosis in the DALK/ KC group (six of eleven DALK/KC patients).
Because of the small number of cases in this study, the occurrence of the postoperative complications could not be compared. Visual improvement was obtained after DALK in patients with or without amyloidosis (Table 1) . However, the average corneal astigmatism at the last visit was 7.92 and 2.95 D in patients with or without corneal amyloidosis, respectively. Recurrence of amyloidosis at the corneal graft or graft-host junction (observed in three cases) may cause unpredictable corneal astigmatism ( Figure 2C 
Discussion
In this study, we aimed to identify the characteristics and influencing factors of unfavorable graft reactions after DALK. Here, we report seven cases of corneal graft complications in the early postoperative period (ie, within 2 months of DALK for KC). These reactions occurred during application of postoperative steroid eye drops and were characterized by PED, suture-related problems (suture infiltration and loosening), graft dislocation, topical infiltration, vessel invasion (vascularization), and graft melting. unable to compare the surgical outcomes among the three groups. Nonetheless, however, these inflammatory graft reactions in the early postoperative period seem to be specific to DALK/KC patients.
These graft reactions in the early postoperative period resemble immune reactions, particularly corneal stromal rejection. [4] [5] [6] However, they occurred much earlier than previously reported reactions 4, 6, 10, 12 and were nonresponsive to topical steroids. Moreover, the reactions occurred during application of 0.1% betamethasone phosphate eye drops for suppressing postoperative inflammation. We were required to remove the sutures and to add interrupted sutures, and even so, it took patients several months to recover from the complications. The incidence of graft rejection-like reactions was 7/11 (68.6%), which is higher than the incidence of corneal stromal rejection (1.0%-23.8%), as reported previously. [3] [4] [5] [6] [7] [8] [9] 11, 12 The reason for the higher incidence among patients with KC is unknown.
According to Jones et al, 13 DALK for KC has a higher graft failure rate than PKP, which is largely explained by early failures related to coexistent atopic dermatitis and the surgeon's inexperience. Although their findings are not directly related to our cases, "co-existent atopic dermatitis" should be replaced with the host patient's background and "surgeon's inexperience" with the surgical techniques. All of the eleven DALK/KC patients in our series had allergic problems (seven patients had atopic dermatitis and the remaining four patients had allergic rhinitis). These allergic conditions may lead to postoperative graft-host immune responses 16, 17 even after DALK. 11 Another important feature of our DALK/KC patients was the high incidence of secondary corneal amyloidosis. Postoperative inflammatory graft reactions occurred equally in patients with or without secondary corneal amyloidosis. However, the host corneal stroma, which contributes to amyloid deposition in KC, may be related to graft rejection, even though the deposition is subclinical. 18, 19 As for the surgical techniques, our manual trephination and layer-by-layer technique during removal of stromal tissue usually leave the deep stromal tissue in the graft bed, and the uniform cutting depth cannot be obtained at the host-graft junction, especially in patients with KC. It is possible that the partial discrepancy of the graft thickness and the depth of the graft bed may cause uneven tension of the running suture of the corneal graft, thereby inducing suture infiltration and loosening. 20, 21 Although the clarity of the corneal graft, especially in the pupillary area, could be obtained in many cases after the inflammatory reactions diminished, we have to face unpredictable corneal astigmatism. Because of the high astigmatism, contact lenses of the rigid type were needed to obtain good visual acuity in DALK/KC patients. Despite the clarity of the corneal graft, high astigmatism due to the irregularity of the graft can cause graft failure. 22 In this study, four of eleven DALK/KC patients revealed corneal 
2321
graft rejection-like reactions in the early postoperative period astigmatism of more than 5.0 D, which might be considered graft failure, even though good-corrected visual acuity was achieved (cases #2, #5, #6, and #7). Several reports have indicated a good postoperative course of lamellar keratoplasty with complete baring of DM; [23] [24] [25] [26] to avoid an irregular host-stromal junction, a femtosecond laser could possibly be used for the side-cut incision instead of manual trephination. 27, 28 Furthermore, glues could be used instead of nylon sutures to minimize inflammation after surgery. 29 However, because of the unpredictable graft reactions due to the pathologic corneal stroma, its indication for patients with KC should be reconsidered carefully.
The main limitation of this study was the single-center study design. Additional information from other institutions is needed to clarify the etiology of graft rejection-like reactions after DALK. This could help devise a method to prevent such reactions in patients with KC.
Conclusion
Inflammatory graft reactions characterized by PED, loosening of the suture with infiltration, infiltration in the wider area of the graft, vessel invasion, and graft melting may occur in the early postoperative period after DALK for KC. These reactions do not respond well to topical steroids, and suture removal is required. Although clear corneal graft at the pupillary area was obtained and BCVA was good after the resolution of inflammation, there remains a risk of unpredictable corneal astigmatism. These reactions may be caused by the patient's background, that is, coexistent atopic dermatitis or allergic rhinitis, younger age, complication of secondary corneal amyloidosis, and the surgical technique without exposing DM, especially at the peripheral graft bed. Because of these corneal stromal reactions, the indication of lamellar keratoplasty or DALK for patients with KC should be considered carefully.
Unfavorable graft reactions occurred in the early postoperative period after DALK for KC and may be specific to patients with KC.
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